InMed Pharmaceuticals Inc. — Investor Relations & Filings
Filings indexed
464
across all filing types
Latest filing
2026-05-19
Regulatory Filings
Country
CA
Canada
Listing
US
INM
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company developing a pipeline of proprietary small molecule drug candidates that target the CB1 and CB2 cannabinoid receptors. The company's therapeutic pipeline includes preclinical programs for Alzheimer's disease (INM-901) and dry age-related macular degeneration (INM-089). In dermatology, InMed has completed a Phase 2 clinical trial for the treatment of epidermolysis bullosa. Additionally, its subsidiary, BayMedica, manufactures and supplies high-purity, rare cannabinoids such as cannabichromene (CBC), tetrahydrocannabivarin (d9-THCV), and cannabidivarin (CBDV) as raw ingredients for the business-to-business health and wellness market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| CURRENT REPORT | 2026-05-19 | English | |
| FORM 8-K | 2026-05-19 | English | |
| 10-Q - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-05-06 | English | |
| 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | |
| 424B5 - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | |
| 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-03-23 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46543393 | CURRENT REPORT | 2026-05-19 | English | ||
| 46531524 | FORM 8-K | 2026-05-19 | English | ||
| 42033060 | 10-Q - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-05-06 | English | ||
| 33301130 | 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | ||
| 33301119 | 424B5 - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | ||
| 33012916 | 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-03-23 | English | ||
| 33002557 | S-3 - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-03-20 | English | ||
| 32897365 | 8-K - INMED PHARMACEUTICALS INC. (0001728328) (Filer) | 2026-02-12 | English | ||
| 31504961 | 10-Q Filing | 2026-02-11 | English | ||
| 31504697 | SCHEDULE 13G Filing | 2026-01-20 | English | ||
|
2025
5 filings
| |||||
| 13089323 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089322 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089324 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089325 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089326 | Director's Dealing 2025 | 2025-12-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abbott Laboratories (Pakistan) Limited
Manufactures and markets diverse healthcare products: pharm…
|
ABOT | PK | Manufacturing |
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
InMed Pharmaceuticals Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35386/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35386 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35386 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35386 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35386}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for InMed Pharmaceuticals Inc. (id: 35386)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.